Table 3.

Comparison of the cardiometabolic profile and variations over time between adverse responders (n = 12) in blood pressure and other participants (n = 89).

Variable	Baseline (T0)			End of Intervention (T12)			Variations between T0 and T12
	AR	OP	p Value	AR	OP	p Value	AR	OP	p Value
	(n = 12)	(n = 89)		(n = 12)	(n = 89)		(n = 12)	(n = 89)
Body weight (kg)	93.4 ± 16.7	87.4 ± 13.4	NS	92.2 ± 15.6	84.5 ± 13.3	0.0668	−1.1 ± 3.1	−2.9 ± 4.3	NS
Body mass index (kg/m2)	32.6 ± 4.4	31.1 ± 3.3	NS	32.2 ± 4.1	30.0 ± 3.4	0.0468	−0.4 ± 1.1	−1.0 ± 1.5	NS
Waist circumference (cm)	107.0 ± 11.0	105.7 ± 9.7	NS	106.7 ± 11.6	100.9 ± 10.2	0.0758	−0.4 ± 3.5	−4.7 ± 4.9	0.0038
Systolic blood pressure (mm Hg)	125.9 ± 14.4	135.0 ± 12.5	0.0222	133.0 ± 14.9	128.7 ± 12.3	NS	7.1 ± 3.9	−6.3 ± 9.7	<0.0001
Diastolic blood pressure (mm Hg)	75.9 ± 9.99	80.6 ± 8.7	0.0860	81.2 ± 8.5	76.2 ± 7.9	0.0467	5.3 ± 5.2	−4.4 ± 6.3	<0.0001
Total cholesterol (mmol/L)	4.55 ± 1.50	4.88 ± 1.38	NS	4.04 ± 1.6	4.71 ± 1.2	0.0891	−0.51 ± 0.89	−0.17 ± 0.63	NS
LDL-cholesterol (mmol/L)	2.26 ± 1.23	2.76 ± 1.11	NS	2.17 ± 1.19	2.65 ± 1.02	NS	−0.09 ± 0.55	−0.11 ± 0.56	NS
HDL-cholesterol (mmol/L)	1.21 ± 0.25	1.20 ± 0.28	NS	1.20 ± 0.24	1.24 ± 0.29	NS	−0.01 ± 0.13	0.04 ± 0.18	NS
Plasma triglycerides (mmol/L)	2.36 ± 1.46	2.10 ± 1.00	NS	1.92 ± 0.73	1.87 ± 0.89	NS	−0.45 ± 1.00	−0.22 ± 0.69	NS
Fasting plasma glucose (mmol/L)	6.34 ± 1.30	6.27 ± 1.39	NS	6.28 ± 1.14	6.19 ± 1.32	NS	−0.06 ± 0.47	−0.08 ± 0.96	NS
VO2max (mLO2/kg/min)	33.7 ± 4.5	33.1 ± 6.6	NS	36.8 ± 64.4	35.7 ± 6.7	NS	3.2 ± 2.6	2.6 ± 2.5	NS

Values are mean ± SD. Abbreviations: AR, adverse responders; OP, other participants.